UNSPSC 51431807: Methyldopa sesquihydrate

This classification denotes a dopamine agonist and antihypertensive agent with the molecular formula 2C10H13NO4.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 56LH93261Y, chemically known as l-3-(3,4-dihydroxyphenyl)-2-methylalanine sesquihydrate, but more generally known as methyldopa sesquihydrate, which bears US NIH Compound Identifier 38852. European Medicines Agency schedules methyldopa sesquihydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08867MIG.

Most nations, for tariff purposes, schedule methyldopa sesquihydrate under HS 29225000. SMILES: C[C@](CC1CCC(C(C1)O)O)(C(=O)O)N.C[C@](CC1CCC(C(C1)O)O)(C(=O)O)N.O.O.O.

UNSPSC 51431807 Methyldopa sesquihydrate is a Commodity code that does not appear to match the work actually being solicited under it in recent state and local opportunities. The source identifies three recent opportunities tagged to this code: the City of Tampa's procurement of Advanced Life Support Medications (including Labetalol HCI, Epinephrine, Adenosine, and Diltiazem), the Texas Health and Human Services Commission's Request for Information on Direct-to-Manufacturer Prescriptions, and the Minnesota Multistate Cooperative Purchasing Alliance's (MMCAP) multi-state RFP for Generic Multi Source Pharmaceuticals and OTC Products. While methyldopa sesquihydrate is a legitimate antihypertensive pharmaceutical, none of the three recent opportunities explicitly mentions methyldopa or sesquihydrate as a line item, and the Tampa and MMCAP solicitations call for different active ingredients entirely. The code shows little relevant recent activity aligned with its stated commodity name.

The geographic spread across recent opportunities spans Florida (City of Tampa), Texas (HHS Commission), and Minnesota (MMCAP, serving multiple states including Oregon). Issuing bodies include municipal fire-rescue agencies, state health and human services departments, and state cooperative purchasing alliances. The Tampa Fire Rescue bid (26P00188, due April 8, 2026) sought sealed bids for four named medications at an estimated contract value of $40,000.00, with a Small Local Business Enterprise 5 percent bid discount; MMCAP's RFP (S1070000015802, due March 26, 2026) seeks manufacturers of generic and OTC pharmaceutical products across three authorized wholesalers for a two-year contract term effective July 1, 2026; and the Texas HHS RFI (HHS0017013, posted April 3, 2026) is exploratory market intelligence on direct-to-manufacturer prescription programs with no award values or budget range disclosed. The mismatch between the code's specific commodity designation and the broad, multi-product nature of actual recent solicitations suggests that this code may be miscategorized in the source data or that issuing bodies are applying it inconsistently.